Quidel's C. difficile test gets FDA OK for Life's Dx platforms

03/19/2013 | GenomeWeb Daily News (free registration)

Quidel has received FDA clearance for its Molecular Direct C. difficile Assay to be used with the 7500 Fast Dx Applied Biosystems Real-Time PCR Instrument and QuantStudio Dx from Life Technologies. The test kit uses a three-step, extraction-free specimen preparation process and takes under 70 minutes to generate results, the companies said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX